Perrigo | PRGO - Cost Of Sales


Perrigo reported $643.7M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Abbott USD 5.3B 380M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Corcept Therapeutics USD 2.88M 338K Mar/2026
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Eli Lilly USD 3.58B 205M Mar/2026
J&J USD 8.07B 103M Mar/2026
Merck USD 2.94B 380M Mar/2026
Nestle CHF 25.08B 1.48B Dec/2025
Pacira USD 50.74M 3.89M Mar/2026
Perrigo USD 643.7M 103.7M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 140.76M 9.53M Mar/2026
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
Sanofi EUR 3.67B 621M Mar/2026
Supernus Pharmaceuticals USD 49.04M 1.5M Mar/2026
Teva Pharmaceutical Industries USD 2.01B 46M Mar/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026
Zoetis USD 672M 71M Mar/2026